Robert Andrade - 20 Dec 2021 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Chief Financial Officer
Signature
/s/ Robert Andrade, Chief Financial Officer
Issuer symbol
FENC
Transactions as of
20 Dec 2021
Net transactions value
$0
Form type
4
Filing time
20 Dec 2021, 16:48:22 UTC
Previous filing
03 Jun 2021
Next filing
22 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Option (right to buy) Award $0 +75,000 $0.000000 75,000 20 Dec 2021 Common Shares 75,000 $4.08 Direct F1, F3
transaction FENC Restricted Share Unit (right to receive value of a share) Award $0 +37,500 $0.000000 37,500 20 Dec 2021 Common Shares 37,500 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 20, 2021, Robert Andrade was granted an incentive stock option to purchase 75,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F2 On December 20, 2021, Robert Andrade was granted restricted share units to receive 37,500 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F3 Item vests 100% upon FDA approval of PEDMARKTM.